Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Type 2 diabetes and coronary heart disease: Focus on myocardial infarction

(2009) Rodrigo M. Lago et al.   Current Diabetes Reports

Standards of Medical Care in Diabetes--2010

(2009)   DIABETES CARE

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

(2009) Peter Sleight et al.   JOURNAL OF HYPERTENSION

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

(2009) Kausik K Ray et al.   LANCET

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

(2008)   DIABETES CARE

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

(2008) Jan Östergren et al.   JOURNAL OF HYPERTENSION

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

(2007) Jørn Wetterslev et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY